No Data
No Data
Earnings Preview: FibroGen to Report Financial Results Post-market on November 12
FibroGen to Report Third Quarter 2024 Financial Results
FibroGen, Inc. (NASDAQ:FGEN) Not Doing Enough For Some Investors As Its Shares Slump 27%
FibroGen Inc (FGEN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Shifts
Q3 Pharma and Biotech Layoffs in Charts: More Than 1000 Each in July and August
FibroGen Cuts Costs by Terminating San Francisco Lease Early
No Data
No Data